New diabetes clinical trial: Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes
Published on: April 28, 2023 at 09:30PM
Condition: Type 2 Diabetes
Interventions: Drug: THDB0206 Injection; Drug: Insulin Lispro Injection
Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd
Recruiting
https://ift.tt/p8DYfZL
Condition: Type 2 Diabetes
Interventions: Drug: THDB0206 Injection; Drug: Insulin Lispro Injection
Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd
Recruiting
https://ift.tt/p8DYfZL
Comments
Post a Comment